OPY Acquisition Corp. I (OHAAU) Stock Analysis
DELISTED 2023
What happened to OPY Acquisition Corp. I (OHAAU) stock?
OPY Acquisition Corp. I (OHAAU) no longer trades on public markets. It was delisted in October 2023. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
OPY Acquisition Corp. I (OHAAU) trades at $10.76. OPY Acquisition Corp. I is a shell company focused on merging with or acquiring a business in the healthcare industry. Market cap: $55.5M, Sector: Financial services.
Last analyzed: Mar 18, 2026Analyst Coverage for OHAAU: OHAAU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates OHAAU against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
OHAAU: 1/2 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →OPY Acquisition Corp. I (OHAAU) Financial Services Profile
OPY Acquisition Corp. I is a special purpose acquisition company (SPAC) targeting the healthcare sector for a potential merger, share exchange, or acquisition. The company seeks to identify and combine with an existing healthcare business, offering investors exposure to the healthcare industry through a publicly traded vehicle.
What Is the Investment Thesis for OHAAU?
Investing in OPY Acquisition Corp. I presents a speculative opportunity tied to the successful identification and acquisition of a promising healthcare business. The company's current market capitalization is $0.06 billion, and its high P/E ratio of 7833.79 reflects its status as a SPAC awaiting a target acquisition. A successful merger could lead to significant value appreciation if the acquired company performs well. However, the investment is subject to risks, including the failure to find a suitable target, unfavorable deal terms, or poor performance of the acquired company post-merger. The company's low beta of 0.01 suggests minimal correlation with the broader market, making it a potentially diversifying asset, but also highlighting its dependence on specific deal-related events. Investors should carefully assess the management team's expertise in the healthcare sector and their track record in executing successful acquisitions.
Based on FMP financials and quantitative analysis
OHAAU Key Highlights
Market capitalization of $55.5M indicates a small-cap SPAC.
- P/E ratio of 7833.79 reflects the company's current lack of significant operations and anticipation of a future merger.
- Beta of 0.01 suggests low volatility and minimal correlation with the overall market.
- The company's focus on the healthcare sector aligns with a growing and potentially lucrative market.
- No dividend yield reflects the company's focus on growth through acquisitions rather than returning capital to shareholders.
Who Are OHAAU's Competitors?
OHAAU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BRAC Broad Capital Acquisition Corp. | $11.70 | +0.00% | $55.1M | 44 |
| CLRC ClimateRock | $12.00 | +100.00% | $56.0M | 51 |
| GMFI Aetherium Acquisition Corp. | $11.04 | -3.66% | $56.4M | 44 |
| HHGC HHG Capital Corporation | $11.12 | +0.09% | $56.2M | 63 |
| PEPL PepperLime Health Acquisition Corporation | $10.93 | +0.18% | $55.4M | 44 |
| MAAQ Mana Capital Acquisition Corp. | $5.99 | -24.18% | $57.0M | 61 |
| RCLFU Rosecliff Acquisition Corp I | $11.33 | +11.74% | $77.2M | 62 |
| MMTXU Miluna Acquisition Corp is a blank check company incorporated in 2025, focusing on mergers, acquisitions, and similar business combinations. The company | $10.75 | +6.44% | $82.7M | 65 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are OHAAU's Key Strengths?
Experienced management team with healthcare industry expertise.
- Access to capital through public markets.
- Flexibility to pursue a variety of transaction structures.
- Potential for high returns if a successful acquisition is completed.
What Are OHAAU's Weaknesses?
Lack of operating history.
- Dependence on finding a suitable acquisition target.
- Limited control over the acquired company's performance post-merger.
- Risk of liquidation if no suitable target is found within the specified timeframe.
What Could Drive OHAAU Stock Higher?
Announcement of a definitive agreement to merge with or acquire a healthcare company.
- Completion of the merger or acquisition transaction.
- Positive performance of the acquired company post-merger.
- Realization of operational synergies and cost savings.
- Expansion into new markets or product lines.
What Are the Key Risks for OHAAU?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Failure to find a suitable acquisition target within the specified timeframe, leading to liquidation.
- Unfavorable deal terms in a merger or acquisition agreement.
- Poor performance of the acquired company post-merger.
- Increased competition from other SPACs.
- Regulatory changes in the healthcare industry.
What Are the Growth Opportunities for OHAAU?
- Healthcare Industry Growth: The healthcare sector is experiencing sustained growth driven by an aging population, technological advancements, and increasing healthcare spending. OPY Acquisition Corp. I can capitalize on this trend by acquiring a company in a high-growth sub-sector, such as telehealth, biotechnology, or medical devices.
- Operational Synergies: By acquiring a company with complementary technologies or services, OPY Acquisition Corp. I can create operational synergies and improve efficiency. This could involve consolidating back-office functions, cross-selling products, or leveraging existing distribution networks. The potential for cost savings and revenue enhancements can significantly enhance the value of the combined entity.
- Geographic Expansion: OPY Acquisition Corp. I can pursue geographic expansion by acquiring a company with a strong presence in a specific region or country. This can provide access to new markets and customers, diversifying the company's revenue streams and reducing its reliance on any single geographic area. The global healthcare market is highly fragmented, offering opportunities to consolidate regional players and create a larger, more diversified company.
- Technological Innovation: Acquiring a company with innovative technologies can provide OPY Acquisition Corp. I with a competitive edge and drive future growth. This could involve acquiring a company with a proprietary drug delivery system, a novel diagnostic tool, or a cutting-edge medical device. The healthcare industry is constantly evolving, and companies that embrace technological innovation are more likely to succeed in the long run.
- Strategic Partnerships: OPY Acquisition Corp. I can form strategic partnerships with other companies in the healthcare sector to expand its reach and capabilities. This could involve partnering with a pharmaceutical company to co-develop a new drug, or partnering with a hospital system to implement a new technology. Strategic partnerships can provide access to new markets, technologies, and expertise, enhancing the company's competitive position.
What Are OHAAU's Competitive Advantages?
- Management team's expertise in the healthcare sector.
- Network of relationships with potential target companies.
- Access to capital through the public markets.
- Ability to provide a faster and more efficient path to public listing compared to a traditional IPO.
What Does OHAAU Do?
OPY Acquisition Corp. I, incorporated in 2020 and based in New York, operates as a special purpose acquisition company (SPAC). The company's primary objective is to identify and complete a business combination with a company in the healthcare industry. This includes potential mergers, share exchanges, asset acquisitions, stock purchases, reorganizations, or similar transactions. As a shell company, OPY Acquisition Corp. I currently has no significant operations of its own. The company was formed to provide a vehicle for a private healthcare company to become publicly listed without undergoing the traditional initial public offering (IPO) process. By merging with or being acquired by OPY Acquisition Corp. I, a private company can gain access to public markets and capital more quickly and efficiently. The success of OPY Acquisition Corp. I depends on its ability to identify a suitable target company, negotiate favorable terms, and complete the transaction within a specified timeframe, typically within two years of its IPO. The company's activities are centered around deal sourcing, due diligence, and transaction execution within the healthcare sector.
What Products and Services Does OHAAU Offer?
- Identify potential merger targets within the healthcare industry.
- Conduct due diligence on potential acquisition targets.
- Negotiate terms of a merger or acquisition agreement.
- Raise capital to finance the acquisition.
- Complete a business combination with a target company.
- Provide a private healthcare company with a path to becoming publicly listed.
How Does OHAAU Make Money?
- OPY Acquisition Corp. I raises capital through an initial public offering (IPO).
- The company uses the IPO proceeds to fund a future acquisition.
- If a suitable target is found and the acquisition is completed, the company generates returns for its shareholders through the growth and profitability of the acquired business.
- If no suitable target is found within a specified timeframe (typically two years), the company liquidates and returns the IPO proceeds to its shareholders.
What Industry Does OHAAU Operate In?
OPY Acquisition Corp. I operates within the special purpose acquisition company (SPAC) segment of the financial services industry. SPACs have become a popular alternative to traditional IPOs, offering private companies a faster and more streamlined path to public listing. The healthcare sector has been a particularly active area for SPAC mergers, driven by innovation, demographic trends, and increasing demand for healthcare services. The competitive landscape includes numerous SPACs seeking targets in various industries, requiring OPY Acquisition Corp. I to differentiate itself through its deal sourcing capabilities and industry expertise.
Who Are OHAAU's Key Customers?
- Institutional investors seeking exposure to the healthcare industry.
- Private healthcare companies seeking a path to public listing.
- Shareholders who benefit from potential value appreciation following a successful acquisition.
Company Profile
OPY Acquisition Corp. I operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York City, US. The company is led by CEO Jonathan B. Siegel. OHAAU has traded publicly since 2021.
How OPY Acquisition Corp. I Is Valued
OPY Acquisition Corp. I carries a market capitalization of $55.5M, placing it in the micro-cap category.
Key Financial Metrics
Return on equity for OPY Acquisition Corp. I stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.1%, showing how much profit it generates from its asset base. Its free cash flow yield is -1.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.99 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
OPY Acquisition Corp. I's Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 25.53 places it in the safe zone, indicating low near-term bankruptcy risk.
OHAAU Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that key stakeholders believe in its growth potential.
- Community sentiment has shifted positively, with discussions highlighting the company's strategic positioning in the market and potential for acquisition opportunities.
- Increased engagement in social trading platforms shows that retail investors are optimistic about the company's upcoming developments and announcements.
- Recent news around SPACs has renewed interest in acquisition targets, positioning OPY Acquisition Corp. favorably in the current market climate.
Bear Case
- Concerns over the overall SPAC market performance persist, with many investors feeling cautious about future mergers and acquisitions.
- Some community members express skepticism regarding the company's ability to identify and execute successful acquisitions, raising doubts about long-term viability.
- Recent discussions have highlighted a lack of transparency in the company's operations, leading to uncertainty among potential investors.
- Market sentiment remains mixed, with bearish voices pointing to macroeconomic factors that could hinder the performance of SPACs in general.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
OHAAU Latest News
No recent news available for OHAAU.
Classification
Industry Shell CompaniesLeadership: Jonathan B. Siegel
CEO
Jonathan B. Siegel serves as the CEO of OPY Acquisition Corp. I. His background includes extensive experience in investment banking and financial services. He has held leadership positions at various financial institutions, focusing on mergers and acquisitions, capital markets, and strategic advisory services. His expertise spans across multiple sectors, providing him with a broad understanding of business operations and financial management. He is responsible for leading the company's efforts to identify and execute a successful business combination.
Track Record: Under Jonathan B. Siegel's leadership, OPY Acquisition Corp. I is actively pursuing potential merger targets within the healthcare industry. His strategic focus is on identifying companies with strong growth potential and innovative technologies. While the company has not yet completed an acquisition, his efforts are centered on creating value for shareholders through a well-executed business combination. His experience in deal structuring and negotiation is expected to be crucial in achieving a successful outcome.
OHAAU Financial Services Stock FAQ
What happened to OPY Acquisition Corp. I (OHAAU) stock?
OPY Acquisition Corp. I (OHAAU) no longer trades on public markets. It was delisted in October 2023. The figures below are historical and are not a current quote.
Can I still buy OHAAU shares?
No. OHAAU stopped trading on public markets in October 2023, so the shares are not available through a broker. Anything you see quoted for OHAAU elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before OHAAU stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to OPY Acquisition Corp. I. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does OPY Acquisition Corp. I do?
OPY Acquisition Corp. I is a special purpose acquisition company (SPAC) focused on the healthcare sector. As a blank check company, it was formed to raise capital through an initial public offering (IPO) with the sole purpose of acquiring or merging with an existing private healthcare company.
What are the main risks for OHAAU?
The primary risk for OPY Acquisition Corp. I is the failure to identify and complete a suitable acquisition within the specified timeframe, typically two years from its IPO. If no deal is completed, the company will be forced to liquidate and return the IPO proceeds to shareholders, resulting in limited or no return on investment.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- AI analysis is pending and may provide additional insights.